Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Bone Marrow Transplantation|July 1, 1993
Collection of peripheral blood stem cells in multiple myeloma following single high-dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)J M Boiron, G Marit, C Fabéres, et al.
Journal of Hematotherapy|January 1, 1994
Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftmentJ Reiffers, C Faberes, J M Boiron, et al.
Leukemia & Lymphoma|November 1, 1995
Specific antisense oligomer anti Bcr-abl junctions in chronic myeloid leukemia: a cell cycle analysis and CFU-GM studyF X Mahon, F Belloc, I Vianes, et al.
Hematology and Cell Therapy|October 10, 1998
Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literatureD Gruson, G Hilbert, A Pigneux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfaF X Mahon, X Delbrel, P Cony-Makhoul, et al.
The European Respiratory Journal|June 11, 1999
Severe respiratory failure requiring ICU admission in bone marrow transplant recipientsD Gruson, G Hilbert, L Portel, et al.
Leukemia|December 1, 1995
Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factorsM Montastruc, F X Mahon, C Fabères, et al.
La Nouvelle Presse Medicale|May 30, 1981
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)]J Rouesse, T Tursz, T Le Chevalier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2007
p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-alpha and melphalanJ Muret, M Yacoub, P Terrier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupA Le Cesne, I Judson, D Crowther, et al.
Pageof 37